Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/48144

Type
Article
Copyright
Open access
Sustainable Development Goals
03 Saúde e Bem-Estar
Collections
Share

Statistics
Metadata
Show full item record

LEPROSY POST-EXPOSURE PROPHYLAXIS RISKS NOT ADEQUATELY ASSESSED
Lockwood, Diana N. et al. | Date Issued: 2021
Author
Lockwood, Diana N.
Barros, Barbara de
Negera, Edessa
Gonçalves, Heitor
Hay, Roderick J.
Kahawita, Indira P.
Singh, Rajni Kant
Kumar, Bhushan
Lambert, Saba M.
Pai, Vivek
Penna, Gerson Oliveira
Prescott, Geoff
Arquer, Guilllermo Robert de
Talhari, Sinesio
Srikantam, Aparna
Walker, Stephen L.
Affilliation
London School of Hygiene & Tropical Medicine. London, United Kingdom.
London School of Hygiene & Tropical Medicine. London, United Kingdom.
London School of Hygiene & Tropical Medicine. London, United Kingdom.
Dona Libania Dermatology Center. Fortaleza, CE, Brazil.
King's College London. London, United Kingdom.
Nawaloka Hospital. Sri Lanka.
LEPRA India. Patna, BR, India.
Shalby Hospital. SAS Nagar, PB, India.
Bombay Leprosy Project. Mumbai, MH, India.
Universidade de Brasilia. Tropical Medicine Centre. Brasilia, DF, Brazil / Fundação Oswaldo Cruz. Escola Fiocruz de Governo. Brasília, DF, Brasil.
LEPRA UK. Colchester, United Kingdom.
Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta. Manaus, AM, Brazil.
LEPRA Blue Peter Public Health and Research Centre. Hydedrabad, AP, India / Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil.
Keywords
Leprosy
Rifampicin
Communicable diseases
 
DeCS
Hanseníase
Doenças Transmissíveis
Rifampina
 
Publisher
Elsevier
Citation
LOCKWOOD, Diana N. J. et al. Leprosy post-exposure prophylaxis risks not adequately assessed. The Lancet, [s.l.], v. 9, p. e400-e401, Apr. 2021.
DOI
10.1016/S2214-109X(21)00046-2
ISSN
1474-547X